ResearcherOkayama UniversityActive in the last 2 years

Takeyoshi Nishiyama

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0001-5696-6694; OpenAlex author ID A5050241820, A5130166372. Sources: OpenAlex.

Their work

Papers: 6
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 19

Papers, trials and grants by year

2024: 1 paper · 2025: 2 papers · 2026: 3 papers

Papers 6

Mitochondrial inhibition enhances the sensitivity of pancreatic ductal adenocarcinoma cells to oncolytic adenovirus. Co-author DOI 10.1016/j.omton.2026.201180 ↗
p53-armed oncolytic adenovirus induces apoptosis in pancreatic cancer-associated stellate cells via macropinocytosis. Co-author DOI 10.1038/s41417-025-00989-3 ↗
Impact of Cirrhosis Outcome Risk Estimator Score on Outcomes Following Pancreatectomy for Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.21873/invivo.14364 ↗
Precise stratification of prognosis in pancreatic ductal adenocarcinoma patients based on pre- and postoperative genomic information. Co-author DOI 10.1186/s12935-025-03894-9 ↗
Impact of Neoadjuvant Chemotherapy with Gemcitabine Plus S-1 in Patients with Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers17203287 ↗
Robot-Assisted Pancreaticoduodenectomy Using the Anterior Superior Mesenteric Artery-First Approach for Pancreatic Cancer. Co-author DOI 10.1245/s10434-024-16305-6 ↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Toshiyoshi Fujiwara · 6 shared papers, 2024–2026 · strength 1.50
Yasuo Nagai · 5 shared papers, 2024–2026 · strength 1.15
Kazuya Yasui · 4 shared papers, 2024–2026 · strength 1.02
Kosei Takagi · 4 shared papers, 2024–2026 · strength 1.02
Yuzo Umeda · 3 shared papers, 2025–2026 · strength 0.67
Ryuichi Yoshida · 3 shared papers, 2025–2026 · strength 0.67
Yoshinori Kajiwara · 2 shared papers, 2026 · strength 0.48
- Paper Mitochondrial inhibition enhances the sensitivity of pancreatic ductal adenocarcinoma cells to oncolytic adenovirus. DOI 10.1016/j.omton.2026.201180 ↗
- Paper p53-armed oncolytic adenovirus induces apoptosis in pancreatic cancer-associated stellate cells via macropinocytosis. DOI 10.1038/s41417-025-00989-3 ↗
Ryohei Shoji · 2 shared papers, 2026 · strength 0.48
- Paper Mitochondrial inhibition enhances the sensitivity of pancreatic ductal adenocarcinoma cells to oncolytic adenovirus. DOI 10.1016/j.omton.2026.201180 ↗
- Paper p53-armed oncolytic adenovirus induces apoptosis in pancreatic cancer-associated stellate cells via macropinocytosis. DOI 10.1038/s41417-025-00989-3 ↗
Shinji Kuroda · 2 shared papers, 2026 · strength 0.48
- Paper Mitochondrial inhibition enhances the sensitivity of pancreatic ductal adenocarcinoma cells to oncolytic adenovirus. DOI 10.1016/j.omton.2026.201180 ↗
- Paper p53-armed oncolytic adenovirus induces apoptosis in pancreatic cancer-associated stellate cells via macropinocytosis. DOI 10.1038/s41417-025-00989-3 ↗
Yuki Fujii · 2 shared papers, 2025 · strength 0.44
- Paper Impact of Neoadjuvant Chemotherapy with Gemcitabine Plus S-1 in Patients with Resectable Pancreatic Ductal Adenocarcino… DOI 10.3390/cancers17203287 ↗
- Paper Precise stratification of prognosis in pancreatic ductal adenocarcinoma patients based on pre- and postoperative genomi… DOI 10.1186/s12935-025-03894-9 ↗
Kazuyuki Matsumoto · 2 shared papers, 2025 · strength 0.44
- Paper Impact of Neoadjuvant Chemotherapy with Gemcitabine Plus S-1 in Patients with Resectable Pancreatic Ductal Adenocarcino… DOI 10.3390/cancers17203287 ↗
- Paper Precise stratification of prognosis in pancreatic ductal adenocarcinoma patients based on pre- and postoperative genomi… DOI 10.1186/s12935-025-03894-9 ↗
Motoyuki Otsuka · 2 shared papers, 2025 · strength 0.44
- Paper Impact of Neoadjuvant Chemotherapy with Gemcitabine Plus S-1 in Patients with Resectable Pancreatic Ductal Adenocarcino… DOI 10.3390/cancers17203287 ↗
- Paper Precise stratification of prognosis in pancreatic ductal adenocarcinoma patients based on pre- and postoperative genomi… DOI 10.1186/s12935-025-03894-9 ↗
Shigeru Horiguchi · 1 shared paper, 2025 · strength 0.25
- Paper Impact of Neoadjuvant Chemotherapy with Gemcitabine Plus S-1 in Patients with Resectable Pancreatic Ductal Adenocarcino… DOI 10.3390/cancers17203287 ↗
Hiroyoshi Y. Tanaka · 1 shared paper, 2026 · strength 0.23
- Paper p53-armed oncolytic adenovirus induces apoptosis in pancreatic cancer-associated stellate cells via macropinocytosis. DOI 10.1038/s41417-025-00989-3 ↗
Mitsunobu R. Kano · 1 shared paper, 2026 · strength 0.23
- Paper p53-armed oncolytic adenovirus induces apoptosis in pancreatic cancer-associated stellate cells via macropinocytosis. DOI 10.1038/s41417-025-00989-3 ↗
Atsushi Masamune · 1 shared paper, 2026 · strength 0.23
- Paper p53-armed oncolytic adenovirus induces apoptosis in pancreatic cancer-associated stellate cells via macropinocytosis. DOI 10.1038/s41417-025-00989-3 ↗
Kokichi Miyamoto · 1 shared paper, 2025 · strength 0.19
- Paper Precise stratification of prognosis in pancreatic ductal adenocarcinoma patients based on pre- and postoperative genomi… DOI 10.1186/s12935-025-03894-9 ↗
Hironari Kato · 1 shared paper, 2025 · strength 0.19
- Paper Precise stratification of prognosis in pancreatic ductal adenocarcinoma patients based on pre- and postoperative genomi… DOI 10.1186/s12935-025-03894-9 ↗
Kazuhiro Yoshida · 1 shared paper, 2025 · strength 0.19
- Paper Precise stratification of prognosis in pancreatic ductal adenocarcinoma patients based on pre- and postoperative genomi… DOI 10.1186/s12935-025-03894-9 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.